Evaluation of a single-dose PIGRET assay for cisplatin in rats compared with the RBC Pig-a assay

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 811, Issue , 2016, Pages 97-101

  Suzuki, Yuta ^a   Goto, Ken ^a   Nakayama, Yoshihiro ^a   Saratani, Masatoshi ^a   Takata, Takuya ^a   Okamoto, Takezo ^a   Okazaki, Shuzo ^a  

^a Research Center Inc   (Japan)

Author keywords

Genotoxicity; Mutagenicity; Pig a assay; ; Reticulocyte

Indexed keywords

CISPLATIN; SODIUM CHLORIDE; MEMBRANE PROTEIN; MUTAGENIC AGENT; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN;

ANIMAL CELL; ARTICLE; AUTOPSY; BODY WEIGHT; CLINICAL OBSERVATION; CONTROLLED STUDY; ERYTHROCYTE; GENOTOXICITY ASSAY; MALE; MUTAGENICITY; NONHUMAN; PIGRET ASSAY; PRIORITY JOURNAL; RAT; RED BLOOD CELL PIG A ASSAY; RETICULOCYTE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; FISCHER 344 RAT; GENETICS; MUTAGEN TESTING; PROCEDURES;

ANIMALS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; MALE; MEMBRANE PROTEINS; MUTAGENICITY TESTS; MUTAGENS; RATS; RATS, INBRED F344; RETICULOCYTES;

EID: 85002131832     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2016.02.009     Document Type: Article

References (29)

1. [1] Dobrovolsky, V.N., Miura, D., Heflich, R.H., Dertinger, S.D., The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Environ. Mol. Mutagen. 51 (2010), 825–835.
2. [2] Gollapudi, B.B., Lynch, A.M., Heflich, R.H., Dertinger, S.D., Dobrovolsky, V.N., Froetschl, R., Horibata, K., Kenyon, M.O., Kimoto, T., Lovell, D.P., Stankowski, L.F. Jr., White, P.A., Witt, K.L., Tanir, J.Y., The in vivo Pig-a assay: a report of the international workshop on genotoxicity testing (IWGT) workgroup. Mutat. Res. 783 (2015), 23–35.
3. [3] Kimoto, T., Chikura, S., Suzuki, K., Kobayashi, X., Itano, Y., Horibata, K., Honma, M., Dobrovolsky, V.N., Heflich, R.H., Miura, D., Kasahara, Y., Further development of the rat Pig-a mutation assay: measuring rat Pig-a mutant bone marrow erythroids and a high throughput assay for mutant peripheral blood reticulocytes. Environ. Mol. Mutagen. 52 (2011), 774–783.
4. [4] Dertinger, S.D., Phonethepswath, S., Weller, P., Nicolette, J., Murray, J., Sonders, P., Vohr, H.W., Shi, J., Krsmanovic, L., Gleason, C., Custer, L., Henwood, A.K., Stankowski, L.F. Jr., Roberts, D.J., Giddings, A., Kenny, J., Lynch, A.M., Defrain, C., Nesslany, F., van der Leede, B.J., Van Doninck, T., Schuermans, A., Tanaka, K., Hiwata, Y., Tajima, O., Wilde, E., Elhajouji, A., Gunther, W.C., Thiffeault, C.J., Shutsky, T.J., Fiedler, R.D., Kimoto, T., Bhalli, J.A., Heflich, R.H., MacGregor, J.T., International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories. Environ. Mol. Mutagen. 52 (2011), 690–698.
5. [5] Kimoto, T., Horibata, K., Chikura, S., Hashimoto, K., Itoh, S., Sanada, H., Muto, S., Uno, Y., Yamada, M., Honma, M., Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody. Mutat. Res. 755 (2013), 126–134.
6. [6] Kimoto, T., Introduction to a special issue on the Pig-a gene mutation assay. Genes Environ. 36 (2014), 167–168.
7. [7] Miura, D., The in vivo Pig-a gene mutation assay. Genes Environ. 36 (2014), 169–173.
8. [8] Itoh, S., Nagata, M., Hattori, C., Takasaki, W., In Vivo mutagenicity of ethyl methanesulfonate detected by Pig-a and PIGRET assays. Genes Environ. 36 (2014), 174–178.
9. [9] Sanada, H., Okamoto, M., Ohsumi, T., Nakamura, T., Evaluation for a Mutagenicity of 4,4'-methylenedianiline on hematopoietic cells by a Pig-a gene mutation assay in rats. Genes Environ. 36 (2014), 179–185.
10. [10] Muto, S., Yamada, K., Kato, T., Iwase, Y., Uno, Y., Pig-a gene mutation and micronucleus induction in rat peripheral blood by methyl methanesulfonate. Genes Environ. 36 (2014), 186–190.
11. [11] Kimoto, T., Chikura, S., Suzuki-Okada, K., Kobayashi, X., Itano, Y., Miura, D., Kasahara, Y., The rat Pig-a mutation assay in single and 28 day-repeated dose study of cyclophosphamide: the PIGRET assay can detect the in vivo mutagenicity earlier than the RBC Pig-a assay. Genes Environ. 36 (2014), 191–198.
12. [12] Horibata, K., Ukai, A., Honma, M., Evaluation of rats’ in vivo genotoxicity induced by N-ethyl-N-nitrosourea in the RBC Pig-a, PIGRET, and gpt assays. Genes Environ. 36 (2014), 199–202.
13. [13] Rabik, C.A., Dolan, M.E., Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat. Rev. 36 (2007), 9–23.
14. [14] Wang, D., Lippard, S.J., Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 4 (2005), 307–320.
15. [15] Fram, R.J., Cusick, P.S., Marinus, M.G., Studies on mutagenesis and repair induced by platinum analogs. Mutat. Res. 173 (1986), 13–18.
16. [16] Andersen, K.S., Platinum(II) complexes generate frameshift mutations in test strains of Salmonella typhimurium. Mutat. Res. 67 (1979), 209–214.
17. [17] IARC. Cisplatin, in overall evaluations of carcinogenicity. IARC monographs on the evaluation of carcinogenic risk of chemicals to humans, World Health Organization, suppl. 7 (1987) 170–171.
18. [18] Kimoto, T., et al. The PIGRET assay, a method for measuring Pig-a gene mutation in reticulocytes, is reliable as a short-term in vivo genotoxicity test: summary of the MMS/JEMS-collaborative study across 16 laboratoriesusing 24 chemicals. Mutat. Res. 811 (2016), 3–15.
19. [19] Hayashi, T., Watanabe, Y., Kumano, K., Kitayama, R., Muratani, T., Yasuda, T., Saikawa, I., Katahira, J., Kumada, T., Shimizu, K., Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats. Antimicrob. Agents Chemother. 33 (1989), 513–518.
20. [20] Bhalli, J.A., Shaddock, J.G., Pearce, M.G., Dobrovolsky, V.N., Sensitivity of the Pig-a assay for detecting gene mutation in rats exposed acutely to strong clastogens. Mutagenesis 28 (2013), 447–455.
21. [21] Knight, K.R., Kraemer, D.F., Neuwelt, E.A., Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J. Clin. Oncol. 23 (2005), 8588–8596.
22. [22] Lichtman, S.M., Wildiers, H., Launay-Vacher, V., Steer, C., Chatelut, E., Aapro, M., International society of geriatric oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur. J. Cancer 43 (2007), 14–34.
23. [23] Yoshida, M., Fukuda, A., Hara, M., Terada, A., Kitanaka, Y., Owada, S., Melatonin prevents the increase in hydroxyl radicalspin trap adduct formation caused by the addition of cisplatin in vitro. Life Sci. 72 (2003), 1773–1780.
24. [24] Brahmi, D., Ayed, Y., Hfaiedh, M., Bouaziz, C., Mansour, H.B., Zourgui, L., Bacha, H., Protective effect of cactus cladode extract against cisplatin induced oxidative stress, genotoxicity and apoptosis in balb/c mice: combination with phytochemical composition. BMC Complement. Altern. Med., 12, 2012, 111.
25. [25] Xu, Z., Shaw, J.B., Brodbelt, J.S., Comparison of MS/MS methods for characterization of DNA/cisplatin adducts. Am. Soc. Mass Spectrom. 24 (2013), 265–273.
26. [26] Cross, H.J., Tilby, M., Chipman, J.K., Ferry, D.R., Gescher, A., Effect of quercitin on the genotoxic potential of cisplatin. Int. J. Cancer 66 (1996), 404–408.
27. [27] Dertinger, S.D., Avlasevich, S.L., Torous, D.K., Bemis, J.C., Phonethepswath, S., Labash, C., Carlson, K., Mereness, J., Cottom, J., Palis, J., MacGregor, J.T., Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapy. Toxicol. Sci. 140 (2014), 307–314.
28. [28] Avlasevich, S.L., Phonethepswath, S., Labash, C., Carlson, K., Torous, D.K., Cottom, J., Bemis, J.C., MacGregor, J.T., Dertinger, S.D., Diethylnitrosamine genotoxicity evaluated in Sprague Dawley rats using Pig-a mutation and reticulocyte micronucleus assays. Environ. Mol. Mutagen. 55 (2014), 400–406.
29. [29] Takeiri, A., Mishima, M., Tanaka, K., Shioda, A., Harada, A., Masumura, K.I., Nohmi, T., Mutation spectra in cisplatin-and transplatin-treated GDL1Cells clarified the different mode of action of these compounds in mammalian cells. Genes Environ. 29 (2007), 89–99.